Carroll M A, Balazy M, Margiotta P, Huang D D, Falck J R, McGiff J C
Department of Pharmacology, New York Medical College, Valhalla 10595, USA.
Am J Physiol. 1996 Oct;271(4 Pt 2):R863-9. doi: 10.1152/ajpregu.1996.271.4.R863.
The cytochrome P-450 pathway is capable of metabolizing arachidonic acid to omega- and subterminal hydroxylase metabolites, 16-, 17-, 18-, 19-, and 20-hydroxyeicosatetraenoic acids (P-450 HETEs). We have quantitated, by gas chromatography-mass spectrometry (GC/MS), endogenous HETEs exiting the rabbit isolated perfused kidney elicited by hormonal stimulation. Kidneys were perfused with Krebs-Henseleit solution containing indomethacin (2.8 microM) to prevent further metabolism of HETEs by cyclooxygenase. Phenylephrine (2-3 microM) was added to the perfusate to raise perfusion pressure to approximately 80 mmHg. Angiotensin II (ANG II), arginine vasopressin (AVP), and bradykinin (BK) were injected into the renal artery and perfusates collected throughout the vasoactive response. After addition of an internal standard, deuterated 19-HETE, perfusates were extracted and purified and P-450 HETEs were derivatized for GC/MS analysis. Under basal conditions, 16-, 18-, 19-, and 20-HETEs were released (range: 50-270 pg/ml), 19-HETE being the highest and fivefold greater than 16-HETE, the lowest. Injection of 50 ng ANG II increased by two- to sixfold P-450 HETE release associated with an increase of 40 +/- 11 mmHg in perfusion pressure. An equipressor dose of AVP (50 ng) did not release P-450 HETEs nor did a 5-micrograms dose of the vasodilator peptide BK, which decreased perfusion pressure by 22 +/- 6 mmHg. Authentic 19- and 20-HETE isomers resulted in dose-dependent dilation, as did 18(R)- and 16(R)-HETEs, whereas their enantiomers and 17-HETE isomers were without effect on perfusion pressure. The vasodilator effects of 18(R)- and 16(R)-HETEs, like 20- and 19-HETEs, were inhibited by indomethacin. Furthermore, P-450 HETEs exhibited both regio- and stereoselective inhibition of proximal tubule adenosine triphosphatase (ATPase) activity. The (S) enantiomers of 16- and 17-HETE potently inhibited activity, whereas their (R) isomers and other P-450 HETEs had negligible effects on ATPase activity. The quantity of HETEs released from the kidney, either under basal conditions or when stimulated by ANG II, and their biological profile suggest that subterminal HETEs may participate in renal mechanisms affecting vasomotion and tubular transport.
细胞色素P - 450途径能够将花生四烯酸代谢为ω - 羟化酶和亚末端羟化酶代谢产物,即16 -、17 -、18 -、19 -和20 -羟基二十碳四烯酸(P - 450 HETEs)。我们通过气相色谱 - 质谱联用(GC/MS)对激素刺激引发的兔离体灌注肾中流出的内源性HETEs进行了定量分析。用含有吲哚美辛(2.8微摩尔)的克雷布斯 - 亨塞尔特溶液灌注肾脏,以防止HETEs被环氧化酶进一步代谢。向灌注液中加入去氧肾上腺素(2 - 3微摩尔),使灌注压力升高至约80 mmHg。将血管紧张素II(ANG II)、精氨酸加压素(AVP)和缓激肽(BK)注入肾动脉,并在整个血管活性反应过程中收集灌注液。加入内标氘代19 - HETE后,对灌注液进行提取和纯化,然后将P - 450 HETEs衍生化用于GC/MS分析。在基础条件下,释放出了16 -、18 -、19 -和20 - HETEs(范围:50 - 270皮克/毫升),其中19 - HETE含量最高,比含量最低的16 - HETE高五倍。注射50纳克ANG II使P - 450 HETE释放量增加了2至6倍,同时灌注压力升高了40±11 mmHg。等压剂量的AVP(50纳克)未释放P - 450 HETEs,5微克剂量的血管舒张肽BK也未释放,BK使灌注压力降低了22±6 mmHg。纯的19 -和20 - HETE异构体以及18(R)-和16(R)-HETEs都导致剂量依赖性舒张,而它们的对映体和17 - HETE异构体对灌注压力没有影响。18(R)-和16(R)-HETEs的血管舒张作用,与20 -和19 - HETEs一样,被吲哚美辛抑制。此外,P - 450 HETEs对近端小管三磷酸腺苷酶(ATPase)活性表现出区域和立体选择性抑制作用。16 -和17 - HETE的(S)对映体强烈抑制活性,而它们的(R)异构体和其他P - 450 HETEs对ATPase活性的影响可忽略不计。在基础条件下或受ANG II刺激时从肾脏释放的HETEs的量及其生物学特性表明,亚末端HETEs可能参与影响血管运动和肾小管转运的肾脏机制。